Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 181 participants.
Also called NCT01213368
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 181 participants
- Sponsor
- Registry
-
NCT01213368
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01213368. Randomized; quadruple masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2011-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- DRONEDARONE (SR33589)
- Intervention (Drug)
- placebo
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01213368- Content hash
753456190433c529b31aea94c46075da9c404c264922013eb9402ee3c3d2cc22